| 1 | [SID24810852] | Active | Potency | 1 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | 1 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID24810852] | Active | EC50 | 2.415 | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. [AID2044, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | EC50 | 2.415 [uM] | | BioAssay | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. | | AID | 2044 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID24810852] | Active | Potency | 2.6169 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | 2.6169 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID24810852] | Active | Potency | 7.0795 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 5 | [SID24810852] | Active | Potency | 7.0795 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 6 | [SID24810852] | Active | Potency | 8.1995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID24810852] | Active | Potency | 9.2 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | 9.2 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID24810852] | Active | EC50 | 9.212 | Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells [AID1990, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | EC50 | 9.212 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells | | AID | 1990 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID24810852] | Active | EC50 | 9.966 | Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4 Neuroglioblastoma Cells [AID1994, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | EC50 | 9.966 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4 Neuroglioblastoma Cells | | AID | 1994 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID24810852] | Active | EC50 | 12.726 | Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells [AID1988, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | EC50 | 12.726 [uM] | | BioAssay | Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells | | AID | 1988 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID24810852] | Active | AC50 | 13.19 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis [AID449756, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | AC50 | 13.19 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis | | AID | 449756 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID24810852] | Active | AC50 | 14.19 | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick [AID463229, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | AC50 | 14.19 [uM] | | BioAssay | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick | | AID | 463229 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID24810852] | Active | Potency | 15.8489 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID24810852] | Active | Potency | 16.3535 | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | 16.3535 [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table |  |
|
| 15 | [SID24810852] | Active | Potency | 18.3564 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 16 | [SID24810852] | Active | Potency | 18.3564 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 17 | [SID24810852] | Active | Potency | 18.3564 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 18 | [SID24810852] | Active | Potency | 18.3564 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 19 | [SID24810852] | Active | Potency | 28.1838 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 20 | [SID24810852] | Active | Potency | 65.1308 | qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation [AID540263, Type: confirmatory] | snurportin-1 [Homo sapiens] [gi:5031833] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | 65.1308 [uM] | | BioAssay | qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation | | AID | 540263 | | BioAssay type | confirmatory | | Target | snurportin-1 [Homo sapiens] [gi:5031833] | | PubMed | | | Data Table |  |
|
| 21 | [SID24810852] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 22 | [SID24810852] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 23 | [SID24810852] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 24 | [SID24810852] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 25 | [SID24810852] | Active | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID24810852] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. [AID435005, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. | | AID | 435005 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID24810852] | Active | | | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication [AID1885, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | BioAssay | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication | | AID | 1885 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID24810852] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors [AID1813, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors | | AID | 1813 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID24810852] | Active | | | Leishmania major promastigote HTS [AID1063, Type: screening] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | BioAssay | Leishmania major promastigote HTS | | AID | 1063 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID24810852] | Active | | | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity [AID493131, Type: screening] | protein fosB [Mus musculus] [gi:6679827] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | BioAssay | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity | | AID | 493131 | | BioAssay type | screening | | Target | protein fosB [Mus musculus] [gi:6679827] | | PubMed | | | Data Table |  |
|
| 31 | [SID24810852] | Active | | | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity [AID488896, Type: screening] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488896 | | BioAssay type | screening | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 32 | [SID24810852] | Active | | | HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress [AID2732, Type: screening] | Ddit3 gene product [Mus musculus] [gi:160707929] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | BioAssay | HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress | | AID | 2732 | | BioAssay type | screening | | Target | Ddit3 gene product [Mus musculus] [gi:160707929] | | PubMed | | | Data Table |  |
|
| 33 | [SID24810852] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 34 | [SID24810852] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 35 | [SID24810852] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 36 | [SID24810852] | Inactive | Potency | 0.1636 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | Potency | 0.1636 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 37 | [SID24810852] | Inactive | Potency | 0.9285 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | Potency | 0.9285 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID24810852] | Inactive | Potency | 25.1189 | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 39 | [SID24810852] | Inactive | Potency | 25.1189 | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 40 | [SID24810852] | Inactive | Potency | 28.1838 | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy [AID624291, Type: confirmatory] | Glycoprotein hormones alpha chain [gi:121312] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | Potency | 28.1838 [uM] | | BioAssay | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy | | AID | 624291 | | BioAssay type | confirmatory | | Target | Glycoprotein hormones alpha chain [gi:121312] | | PubMed | | | Data Table |  |
|
| 41 | [SID24810852] | Inactive | Potency | 35.4813 | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression [AID624202, Type: confirmatory] | BRCA1 [Homo sapiens] [gi:1698399] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression | | AID | 624202 | | BioAssay type | confirmatory | | Target | BRCA1 [Homo sapiens] [gi:1698399] | | PubMed | | | Data Table |  |
|
| 42 | [SID24810852] | Inactive | Potency | 35.4813 | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression [AID624202, Type: confirmatory] | BRCA1 [Homo sapiens] [gi:1698399] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression | | AID | 624202 | | BioAssay type | confirmatory | | Target | BRCA1 [Homo sapiens] [gi:1698399] | | PubMed | | | Data Table |  |
|
| 43 | [SID24810852] | Inactive | Potency | 70.7946 | qHTS Assay to Find Inhibitors of Pin1 [AID504891, Type: confirmatory] | PIN1 gene product [Homo sapiens] [gi:5453898] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | Potency | 70.7946 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Pin1 | | AID | 504891 | | BioAssay type | confirmatory | | Target | PIN1 gene product [Homo sapiens] [gi:5453898] | | PubMed | | | Data Table |  |
|
| 44 | [SID24810852] | Inactive | Potency | 70.7946 | qHTS Assay to Find Inhibitors of Pin1 [AID504891, Type: confirmatory] | PIN1 gene product [Homo sapiens] [gi:5453898] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | Potency | 70.7946 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Pin1 | | AID | 504891 | | BioAssay type | confirmatory | | Target | PIN1 gene product [Homo sapiens] [gi:5453898] | | PubMed | | | Data Table |  |
|
| 45 | [SID24810852] | Inactive | AC50 | 260 | Luminescence Cell-Based Counter Screen to Identify Inhibitors of Cytokine Induced Apoptosis [AID463206, Type: confirmatory] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | AC50 | 260 [uM] | | BioAssay | Luminescence Cell-Based Counter Screen to Identify Inhibitors of Cytokine Induced Apoptosis | | AID | 463206 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID24810852] | Inactive | | | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease [AID624483, Type: screening] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | BioAssay | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease | | AID | 624483 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID24810852] | Inactive | | | uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay [AID651582, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay | | AID | 651582 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID24810852] | Inactive | | | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity [AID651610, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | BioAssay | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651610 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID24810852] | Inactive | | | DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity [AID651640, Type: screening] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | BioAssay | DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity | | AID | 651640 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID24810852] | Inactive | | | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity [AID651661, Type: screening] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24810852 | | CID | 56642840 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651661 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|